Curi Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Curi Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $183,383 - $209,470	3,080 Added 1212.6%	3,334 $206,000
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $16,479 - $18,704	254 New	254 $18,000
Q1 2021 Apr 29, 2021	SELL	$60.0 - $68.46 $1,680 - $1,916	-28 Closed	0 $0
Q4 2020 Mar 19, 2021	BUY	$56.65 - $64.55 $1,586 - $1,807	28 New	28 $1,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Curi Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Curi Wealth Management, LLC with notifications on news.